(Q37988309)

26 August 2017

Does equol production determine soy endocrine effects? (English)

1 reference

26 August 2017

Stephen L Atkin

3

0 references

author name string

Dana Shor

series ordinal

1

1 reference

PubMed ID

22366740

26 August 2017

Thozhukat Sathyapalan

series ordinal

2

1 reference

PubMed ID

22366740

26 August 2017

Natalie J Thatcher

series ordinal

4

1 reference

26 August 2017

25 February 2012

1 reference

European Journal of Nutrition

26 August 2017

1 reference

26 August 2017

51

1 reference

26 August 2017

4

1 reference

26 August 2017

389-398

1 reference

https://scigraph.springernature.com/pub.10.1007/s00394-012-0331-7

26 August 2017

0 references

cites work

Dietary phytoestrogens and health

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Equol: history, chemistry, and formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Asaccharobacter celatus gen. nov., sp. nov., isolated from rat caecum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isolation and identification of equol-producing bacterial strains from cultures of pig faeces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Enhanced biosynthesis of dihydrodaidzein and dihydrogenistein by a newly isolated bovine rumen anaerobic bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Stereospecific biotransformation of dihydrodaidzein into (3S)-equol by the human intestinal bacterium Eggerthella strain Julong 732.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isolation and characterization of a novel equol-producing bacterium from human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isolation of a human intestinal bacterium capable of daidzein and genistein conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Antioxidant and free radical scavenging activity of isoflavone metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isoflavone effect on gene expression profile and biomarkers of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Evaluation of bone quality and quantity in osteoporotic mice--the effects of genistein and equol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Effects of isoflavones equol and genistein on bone quality in a rat osteopenia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Localization of estrogen receptor beta protein expression in adult human bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Soy isoflavones and bone mineral density in perimenopausal and postmenopausal Western women: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isoflavones versus hormone therapy for reduction of vertebral fracture risk: indirect comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Equol improves menopausal symptoms in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Adolescent and adult soy intake and risk of breast cancer in Asian-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Case-control study of phyto-oestrogens and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Factors to consider in the association between soy isoflavone intake and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Short-term soy and probiotic supplementation does not markedly affect concentrations of reproductive hormones in postmenopausal women with and without histories of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Urinary equol excretion in relation to 2-hydroxyestrone and 16alpha-hydroxyestrone concentrations: an observational study of young to middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Mammographic densities in a one-year isoflavone intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

The association of breast mitogens with mammographic densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Soy, isoflavones, and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Soy isoflavones in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

The specific role of isoflavones in reducing prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Genistein administration decreases serum corticosterone and testosterone levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Roles of estrogen and SHBG in prostate physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0331-7

Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro

21 January 2018

1 reference

12 December 2020

Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women

1 reference

12 December 2020

Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls

1 reference

12 December 2020

Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients

1 reference

12 December 2020

Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials

1 reference

12 December 2020

The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women

1 reference

12 December 2020

Mammographic densities and breast cancer risk

1 reference

12 December 2020

Method of defining equol-producer status and its frequency among vegetarians

1 reference

12 December 2020

Administration of equol-producing bacteria alters the equol production status in the Simulator of the Gastrointestinal Microbial Ecosystem (SHIME).

1 reference

12 December 2020

Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer

1 reference

12 December 2020

Production of phytoestrogen S-equol from daidzein in mixed culture of two anaerobic bacteria

1 reference

12 December 2020

Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.

1 reference

12 December 2020

In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production

1 reference

12 December 2020

Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans

1 reference

12 December 2020

Metabolism of daidzein and genistein by intestinal bacteria

1 reference

12 December 2020

The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia

1 reference

12 December 2020

Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis

1 reference

12 December 2020

The excretion of lignans in rats -- evidence for an intestinal bacterial source for this new group of compounds

1 reference

12 December 2020

The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women

1 reference

12 December 2020

Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6'-OH-O-dma, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds

1 reference

12 December 2020

Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women

1 reference

12 December 2020

Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin

1 reference

12 December 2020

The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption

1 reference

12 December 2020

Food factors for atherosclerosis prevention: Asian perspective derived from analyses of worldwide dietary biomarkers.

1 reference

12 December 2020

Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease

1 reference

12 December 2020

A meal enriched with soy isoflavones increases nitric oxide-mediated vasodilation in healthy postmenopausal women.

1 reference

12 December 2020

Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk

1 reference

12 December 2020

Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production

1 reference

12 December 2020

Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans.

1 reference

12 December 2020

Effect of soymilk consumption on serum estrogen and androgen concentrations in Japanese men.

1 reference

12 December 2020

Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer

1 reference

12 December 2020

Dietary isoflavones may protect against prostate cancer in Japanese men

1 reference

12 December 2020

Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study

1 reference

12 December 2020

Phytoestrogen concentrations in serum from Japanese men and women over forty years of age.

1 reference

12 December 2020

Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States

1 reference

12 December 2020

Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer

1 reference

12 December 2020

Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial

1 reference

12 December 2020

Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers.

1 reference

12 December 2020

S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora

1 reference

12 December 2020

Metabolism of daidzein by intestinal bacteria from rhesus monkeys (Macaca mulatta).

1 reference

12 December 2020

Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women

1 reference

12 December 2020

Antioxidant efficacy of phytoestrogens in chemical and biological model systems

1 reference

12 December 2020

Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women

1 reference

12 December 2020

The specific role of isoflavones on estrogen metabolism in premenopausal women

1 reference

12 December 2020

Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health

1 reference

12 December 2020

Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women.

1 reference

12 December 2020

Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity

1 reference

12 December 2020

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones

1 reference

12 December 2020

10.1007/S00394-012-0331-7

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22366740